RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. (formerly Cortex Pharmaceuticals, Inc.) is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.

In the News

12/10/2018 – RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit,
December 10 – 12, 2018

December 10, 2018

09/10/18 – RespireRx Pharmaceuticals Inc. Secures Clinical and Commercial Supply of Dronabinol for Obstructive Sleep Apnea with the Signing of a Development and Supply Agreement with Noramco, Inc.

September 10, 2018

07/25/2018 – RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data: Effects of Chronic Systemic Low-impact Ampakine Treatment on Neurotrophin Expression in Rat Brain

July 25, 2018

All News

Brain-Controlled Breathing Disorders

Breathing is a vital function that is controlled by the rhythmic firing of neurons in a few specific brain regions deep in…

Sleep Apnea

According to the National Heart Lung and Blood Institute sleep apnea affects some 18 million Americans. In fact, according to the National Sleep Foundation, about…